Shenzhen Mindray Bio-Medical Electronics Co Ltd banner

Wall St Price Targets

Price Forecast
Based on 16 analysts

+23% Upside
from ¥183.81 today

Shenzhen Mindray Bio-Medical Electronics Co Ltd (300760)’s 12-month stock price forecast through November 2027 has a consensus target of ¥225.42, implying 23% upside. The forecast is based on price targets from 16 Wall Street analysts.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for Shenzhen Mindray Bio-Medical Electronics Co Ltd yet.

Shenzhen Mindray Bio-Medical Electronics Co Ltd Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's stock price target?
Price Target
225.42 CNY

According to Wall Street analysts, the average 1-year price target for Shenzhen Mindray Bio-Medical Electronics Co Ltd is 225.42 CNY with a low forecast of 209.07 CNY and a high forecast of 315 CNY.

What is the Revenue forecast for Shenzhen Mindray Bio-Medical Electronics Co Ltd?
Projected CAGR
14%

Over the last 9 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 7 years is 14%.

What is the Gross Profit forecast for Shenzhen Mindray Bio-Medical Electronics Co Ltd?
Projected CAGR
11%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 11%.

What is the Operating Income forecast for Shenzhen Mindray Bio-Medical Electronics Co Ltd?
Projected CAGR
18%

Over the last 9 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 7 years is 18%.

What is the Pre-Tax Income forecast for Shenzhen Mindray Bio-Medical Electronics Co Ltd?
Projected CAGR
11%

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 3 years is 11%.

What is the Net Income forecast for Shenzhen Mindray Bio-Medical Electronics Co Ltd?
Projected CAGR
10%

Over the last 9 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is 10%.

Back to Top